This lecture was supported by Grant Number 6H79FG000999-01M001 from SAMHSA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of SAMHSA.  

About the speaker

Dr. Benoit H. Mulsant, MD, MS, FRCPC, is a Professor and the Labatt Family Chair of the Department of Psychiatry at the Temerty Faculty of Medicine of the University of Toronto, where he also holds the Labatt Family Chair in Biology of Depression in Late-Life Adults. He is an Adjunct Professor of Psychiatry at the University of Pittsburgh, and a Senior Scientist at the Centre for Addiction and Mental Health (CAMH), Toronto.

Dr. Mulsant earned his MD from the Laval University, Quebec; he completed his internship in internal medicine and neurology at McGill University, and his residency in psychiatry at the University of Pittsburgh. He is a Fellow of the Royal College of Physicians and Surgeons of Canada; a Diplomate in Psychiatry, American Board of Psychiatry and Neurology; and a Distinguished Fellow of the American Psychiatric Association and of American Association for Geriatric Psychiatry. He has been listed in Best Doctors in America and Best Doctors in Canada.

Over the past 30 years, Dr. Mulsant has been an investigator on grants with funding totaling more than $174M in direct costs (including $73M as principal investigator or team leader, and $32M as a co-principal investigator). He has authored and co-authored more than 600 peer-reviewed articles (and 65 book chapters and invited publications). His publications (including some in the New England Journal of Medicine, Lancet, and JAMA) have resulted in more than 44,000 citations and an h-index of 102. As an educator, he has successfully mentored several generations of academic psychiatrists.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Benoit H. Mulsant, MD, MS, FRCPC, reports that he has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. He will be discussing antidepressants and psychotropic medications in their generic form in this presentation. All relationships have been mitigated through review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Octavia Coit, MN, Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.